JACC-Heart Failure

Papers
(The H4-Index of JACC-Heart Failure is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Myeloperoxidase in Heart Failure With Preserved Ejection Fraction242
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status182
Reply163
Editorial Board128
Racial and Genetic Differences in Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired Left Ventricular Function108
Developing a System for Best Performance for Cardiac Transplantation103
Predictors of Incident Heart Failure Diagnosis Setting87
Clinical Inertia Disturbs the Harmonious Treatment of Heart Failure77
Full issue PDF76
Geographic Variation in the Quality of Heart Failure Care Among U.S. Veterans75
Opportunities for Change in Home Health Care in Heart Failure73
Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure70
Correction68
Revisiting ICD Therapy for Primary Prevention64
CHIEF Effects of Sodium Glucose Co-Transporter Inhibitors on Health-Related Quality of Life in Heart Failure62
Wearable Remote Patient Monitoring Devices60
Examination of Initiation Patterns for Sacubitril/Valsartan Among Older Adults With HFrEF in the United States59
Reply58
Eating to Prevent Both Heart and Planetary Failure58
Long-Term Effects of Sotatercept on Right Ventricular Function58
Associations Between Urinary Metal Levels and Incident Heart Failure56
Reply56
Curing Ourselves of Toxic Positivity for Hospital-at-Home54
Reply54
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction52
Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death51
Exercise Blood Pressure in Heart Failure With Preserved and Reduced Ejection Fraction51
Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome50
Tachycardia and Atrial Fibrillation-Related Cardiomyopathies48
Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype48
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia48
Challenges Addressing Prognosis in Advanced Heart Failure47
Thank You for the Privilege46
GDF-15 in Cardiovascular Disease45
Inhibiting Both Neprilysin and Phosphodiesterase Type 944
The Path Toward a More Equitable Transplant System44
Clinical Utility of the H2FPEF Score in Patients With Early Atrial Fibrillation43
The Impact of Social Determinants of Health on Timely Detection in Transthyretin Cardiac Amyloidosis42
Peripheral Venous Pressure Measured With a Novel Miniature Transducer in Heart Failure Patients42
Challenges in Cardiomyopathy Gene Therapy Clinical Trial Design41
Increasing the Utilization of Sac/Val in Elderly HFrEF Patients Eligible for ARNI Treatment40
0.2988121509552